Merck Discussing Use of Molnupiravir in Response to Ebola Outbreak
Merck is exploring potential use of its antiviral drug molnupiravir, originally developed for COVID-19, as a treatment option during the ongoing Ebola outbreak in the Democratic Republic of Congo. The company's chief medical officer mentioned discussions with global health authorities about this repurposing effort.
Tickers: $MRK
Topics: Ebola Merck Molnupiravir public health virus treatment